Literature DB >> 17949836

Presentation of an embolised Amplatzer septal occluder to the main pulmonary artery 2 years after implantation.

Dimitrios N Lysitsas, Ben Wrigley, Pritwith Banerjee, Peter E Glennon, Jitendra M Parmar, Man Fai Shiu, Martin Been.   

Abstract

Percutaneous occlusion techniques of secundum type atrial septal defects have recently become the treatment of choice, delivering excellent results and being associated with a low rate of early and late complications. The investigators report an unusually delayed presentation of acute right heart failure due to Amplatzer septal device embolisation into the main pulmonary artery, 2 years after implantation.

Entities:  

Mesh:

Year:  2007        PMID: 17949836     DOI: 10.1016/j.ijcard.2007.07.072

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

Review 1.  Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-06-23       Impact factor: 1.731

2.  Late embolization of the atrial septal occluder device into the abdominal aorta.

Authors:  Turgay Celik; Cengiz Ozturk; Ugur Bozlar; Atila Iyisoy
Journal:  Indian Heart J       Date:  2016-01-12

3.  The retrieval of atrial septal defect closure device embolized into aortic arch.

Authors:  Hikmet Hamur; Oruc Alper Onk; Husnu Degirmenci; Umit Kahraman; Eftal Murat Bakirci; Osman Nuri Tuncer
Journal:  Intractable Rare Dis Res       Date:  2016-05

4.  Surgical removal of an atrial septal occluder device embolized to the main pulmonary artery.

Authors:  Emre Boysan; Omer Faruk Cicek; Mustafa Cuneyt Cicek; Ziyaddin Hamurcu; Sami Gurkahraman
Journal:  Tex Heart Inst J       Date:  2014-02

5.  Transcatheter closure of an atrial septal defect with high risk of erosion using a Figulla Flex II atrial septal defect occluder.

Authors:  Norio Tada; Yukiko Mizutani; Takashi Matsumoto; Mie Sakurai; Tatsushi Ootomo
Journal:  Cardiovasc Interv Ther       Date:  2017-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.